Literature DB >> 4881961

Value and interpretation of serological tests for the diagnosis of cryptococcosis.

L Kaufman, S Blumer.   

Abstract

MAXIMAL SEROLOGICAL DIAGNOSIS OF CRYPTOCOCCOSIS MAY BE ACCOMPLISHED THROUGH THE CONCURRENT USE OF THREE TESTS: the latex agglutination (LA) test for cryptococcal antigen, and the indirect fluorescent antibody (IFA) and tube agglutination (TA) tests for Cryptococcus neoformans antibodies. These tests were applied to 141 serum and cerebral spinal fluid specimens from 66 culturally proven cases of cryptococcosis and to 42 sera from normal subjects and from patients with other systemic mycotic diseases. The LA test was sensitive and completely specific; of the sera from proven cases, 55% were positive. With the TA test, 37% of the specimens were positive and the test was highly specific. With the IFA test, 38% of the specimens were positive and the test appears to be the least specific of the three. Cross-reactions were most evident with blastomycosis and histoplasmosis case sera. When the three tests were used concurrently, 87% of the cryptococcosis case specimens were positive and permitted a presumptive diagnosis of C. neoformans infections in 61 (92%) of the 66 patients whose specimens were examined.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4881961      PMCID: PMC547794          DOI: 10.1128/am.16.12.1907-1912.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  13 in total

1.  DETECTION OF CRYPTOCOCCUS NEOFORMANS ANTIGEN IN BODY FLUIDS BY LATEX PARTICLE AGGLUTINATION.

Authors:  N BLOOMFIELD; M A GORDON; D F ELMENDORF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  INCREASED SUSCEPTIBILITY TO CRYPTOCOCCOSIS FOLLOWING STEROID THERAPY.

Authors:  J L BENNINGTON; S L HABER; N L MORGENSTERN
Journal:  Dis Chest       Date:  1964-03

3.  Cryptococcus meningitis in a child successfully treated with amphotericin B, with a review of the pediatric literature.

Authors:  B EMANUEL; E CHING; A D LIEBERMAN; M GOLDIN
Journal:  J Pediatr       Date:  1961-10       Impact factor: 4.406

4.  Cryptococcus neoformans in pigeon excreta in New York City.

Authors:  M L LITTMAN; S S SCHNEIERSON
Journal:  Am J Hyg       Date:  1959-01

5.  Effects of a single histoplasmin skin test on the serological diagnosis of histoplasmosis.

Authors:  L Kaufman; R T Terry; J H Schubert; D McLaughlin
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

6.  Experience with a new skin test antigen prepared from Cryptococcus neoformans.

Authors:  A J Atkinson; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1968-04

7.  The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease.

Authors:  R A Vogel
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

8.  Development and evaluation of agglutination and fluorescent antibody procedures for the identification of Cryptococcus neoformans.

Authors:  L Kaufman; S Blumer
Journal:  Sabouraudia       Date:  1965-06

9.  Detection of circulating antibody in human cryptococcosis by means of a bentonite flocculation technique.

Authors:  H R Kimball; H F Hasenclever; S M Wolff
Journal:  Am Rev Respir Dis       Date:  1967-04

10.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

View more
  21 in total

1.  Technology in global health: the need for essential diagnostics.

Authors:  Eric R Houpt; Richard L Guerrant
Journal:  Lancet       Date:  2008-09-13       Impact factor: 79.321

2.  Evaluation of a commercial latex agglutination test kit for cryptococcal antigen.

Authors:  L Kaufman; G Cowart; S Blumer; A Stine; R Wood
Journal:  Appl Microbiol       Date:  1974-03

3.  [Serological tests on semi-wild pigeons and on pigeons immunized with killed bacterial antigen for antibodies against Cryptococcus neoformans (with a contribution to the fluorescence microscopic test for complement fixing antibodies)].

Authors:  E Weiland; K H Böhm; M B Sasu
Journal:  Z Med Mikrobiol Immunol       Date:  1971

4.  [Serological studies on agglutinins against Cryptococcus neoformans in horse and dog as well as cultural studies on the occurrence of Cryptococcus neoformans in dog-lungs].

Authors:  E Weiland; K H Böhm; M B Sasu
Journal:  Z Med Mikrobiol Immunol       Date:  1971

5.  Cryptococcal meningoencephalitis.

Authors:  R A Martin; D Bates; D A Shaw
Journal:  Br Med J       Date:  1975-07-12

6.  Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid.

Authors:  U K Frank; S L Nishimura; N C Li; K Sugai; D M Yajko; W K Hadley; V L Ng
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

7.  Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid.

Authors:  D L Kiska; D R Orkiszewski; D Howell; P H Gilligan
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.

Authors:  M A Dykstra; L Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

Authors:  F Dromer; J Charreire; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.